NUP214 and Alzheimer disease: Furthermore, AAV2-mediated NFAT inhibition increased glutamate transporter-1 expression in hippocampal astrocytes and reduced the number of glutamate-evoked transients (36), suggesting CaN/NFAT-dependent loss of glutamate regulatory properties underlying hyperexcitability in AD.